ribociclib
Sign in to saveAlso known as LEE011, LEE-011
Ribociclib, sold under the brand name Kisqali, is a medication used for the treatment of certain kinds of breast cancer. Ribociclib is a kinase inhibitor. It was developed by Novartis and Astex Pharmaceuticals.
Key facts
- Drug.image
- Ribociclib skeletal.svg
- Drug.image_class
- skin-invert-image
- Drug.image2
- Ribociclib-from-xtal-3D-bs-17.png
- Drug.image_class2
- bg-transparent
- Drug.tradename
- Kisqali
- Drug.MedlinePlus
- a617008
- Drug.DailyMedID
- Ribociclib
- Drug.routes_of_administration
- By mouth
- Drug.class
- Antineoplastic, CDK inhibitor
- Drug.ATC_prefix
- L01
- Drug.ATC_suffix
- EF02
- Drug.legal_AU
- S4
- Drug.legal_CA
- Rx-only
- Drug.legal_US
- Rx-only
- Drug.legal_EU
- Rx-only
- Drug.bioavailability
- Unknown
- Drug.protein_bound
- ~70%
- Drug.metabolism
- Liver (CYP3A4)
via Wikipedia infobox
Wikidata facts
- Mass
- 434.254
Show 5 more facts
- chemical formula
- C₂₃H₃₀N₈O
- canonical SMILES
- CN(C)C(=O)C1=CC2=CN=C(N=C2N1C3CCCC3)NC4=NC=C(C=C4)N5CCNCC5
- NCI Thesaurus ID
- C95701
- World Health Organisation international non-proprietary name
- ribociclib
- Commons category
- Ribociclib
Sources (5)
via Wikidata · CC0
~10 min read
Article
9 sectionsContents
- Medical uses
- Side effects
- Interactions
- Pharmacology
- Pharmacodynamics
- Pharmacokinetics
- Chemistry
- History
- References
{{Infobox drug | image = Ribociclib skeletal.svg | image_class = skin-invert-image | alt = | caption = | image2 = Ribociclib-from-xtal-3D-bs-17.png | image_class2 = bg-transparent
| pronounce = | tradename = Kisqali | Drugs.com = | MedlinePlus = a617008 | DailyMedID = Ribociclib | pregnancy_AU = | pregnancy_AU_comment = | pregnancy_category= | routes_of_administration = By mouth | class = Antineoplastic, CDK inhibitor | ATC_prefix = L01 | ATC_suffix = EF02